1. Home
  2. Live Updates
  3. Ndmm

Live Breaking News & Updates on Ndmm

Stay informed with the latest breaking news from Ndmm on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ndmm and stay connected to the pulse of your community

The Evolving Treatment Paradigm for Transplant Ineligible MM

The expert panel discusses how the standard of care for transplant-ineligible NDMM has evolved and reviews recent updates in this space.

Multiple-myeloma , Evolving-treatment-paradigm , Transplant-ineligible , Mm , Newly-diagnosed-multiple-myeloma , Ndmm , Mm-treatment , Transplant-eligible , Daratumumab , Lenalidomide , Dexamethasone

Highlights from ASH 2023 in Transplant-Eligible NDMM

Experts in multiple myeloma discuss highlights from the ASH 2023 meeting around transplant-eligible NDMM with particular focus on the PERSEUS and GRIFFIN trials and the clinical implications of the results of these studies.

Multiple-myeloma , Mm , Newly-diagnosed-multiple-myeloma , Ndmm , Mm-treatment , Transplant-eligible , Perseus , Griffin-trial , Perseus-trial , Daratumumab , Lenalidomide

Advances in the Treatment of High-Risk MM

Clinical insights on the definition of high-risk multiple myeloma and the treatment of patients with high risk disease, including how the results from the IsKia trial might impact practice.

Multiple-myeloma , Mm , Newly-diagnosed-multiple-myeloma , Ndmm , Mm-treatment , Transplant-eligible , High-risk , Standard-risk , Iskia , Isatuximab , Carfilzomib

Role of Transplant and MRD in Newly Diagnosed MM

Amrita Krishnan, MD, and Saad Z. Usmani, MD, MBA, FACP, offer their perspectives on the role of stem cell transplant and MRD testing in patients with newly diagnosed multiple myeloma.

Saadz-usmani , Multiple-myeloma , Newly-diagnosed , Mm , Newly-diagnosed-multiple-myeloma , Ndmm , Mm-treatment , Transplant-eligible , High-risk , Standard-risk , Quadruplet

Impact of Clinical Trials on the Management of Multiple Myeloma

Continuing its discussion on clinical trials in multiple myeloma, the panel emphasizes the impact that data may have on the real-world treatment landscape.

Joseph-mikhael , Katie-joyner , Multiple-myeloma , Newly-diagnosed-multiple-myeloma , Ndmm , Frontline-therapy , First-line-therapy , First-line-treatment , Clinical-trials , Real-world-data , Standard-of-care

Multiple Myeloma: Regulatory Aspects of Treatment Development and Approval

A focused discussion on the regulatory aspects of drug testing and approval, globally, with respect to the setting of multiple myeloma management.

France , Canada , United-states , Australia , United-kingdom , Australian , America , American , Canadian , Katie-joyner , Joseph-mikhael ,

Treatment for Newly Diagnosed Multiple Myeloma: Addressing Disparities in Care

Comprehensive insight to disparities that may impact a patient’s access to therapy for multiple myeloma and how these may be overcome.

Unmet-needs , Provide-optimal-care , Multiple-myeloma , Newly-diagnosed-multiple-myeloma , Addressing-disparities , Ndmm , Frontline-therapy , First-line-therapy , First-line-treatment , Access-to-care , Healthcare-equity

Treatment Considerations for Patients with Newly Diagnosed Multiple Myeloma

Panelists share a brief discussion on the current treatment armamentarium available to patients with newly diagnosed multiple myeloma.

Unmet-needs , Provide-optimal-care , Multiple-myeloma , Newly-diagnosed-multiple-myeloma , Ndmm , Frontline-therapy , First-line-therapy , First-line-treatment , Combination-therapy , Triplet-therapy , Quadruplet-therapy

Treatment Duration in Patients With Newly Diagnosed Multiple Myeloma

A panel of experts reflects on treatment duration and its role in optimizing management of patients with newly diagnosed multiple myeloma.

Evolving-treatment-paradigm , Multiple-myeloma , Recent-updates , Patients-with-newly-diagnosed-multiple , Myeloma-cancer , Newly-diagnosed-multiple-myeloma , Ndmm , Griffin-trial , Griffin-study , Master-trial , Master-study

What is the Role of Transplant in Newly Diagnosed Multiple Myeloma?

Expert panelists reflect on the continuing role of stem cell transplant in patients with newly diagnosed multiple myeloma.

Evolving-treatment-paradigm , Multiple-myeloma , Recent-updates , Newly-diagnosed-multiple , Myeloma-cancer , Newly-diagnosed-multiple-myeloma , Ndmm , Asct , Stem-cell-transplant , Quadruplet-therapy , Triplet-therapy